Status:
UNKNOWN
Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday
Lead Sponsor:
Meir Medical Center
Conditions:
Osteoporosis
Eligibility:
FEMALE
40-90 years
Brief Summary
The purpose of the study is to provide information about the rate of response and persistence to drug therapies for osteoporosis. Another issue examined in this study refers to the preferences and con...
Eligibility Criteria
Inclusion
- Postmenopausal women
- Diagnosis of osteoporosis in the medical record
- At least one prescription drug to treat osteoporosis in the last 5 years
- Insured by "Clalit" Health Services
- Hebrew-speaking capability and readiness to answer a questionnaire
Exclusion
- Premenopausal women
- No diagnosis of osteoporosis in the medical record
- No treatment for osteoporosis in the last 5 years
- Women who do not speak Hebrew or are unable to answer a questionnaire
Key Trial Info
Start Date :
September 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01854086
Start Date
September 1 2013
Last Update
May 15 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Meir medical center the clalit health care services group
Kfar Saba, Israel, 44281